Skip to content
Subscriber Only

FDA Ousts Spokeswoman After Covid Therapy Misstatements

  • Emily Miller joined the agency as chief spokeswoman this month
  • Move comes after FDA chief exaggerated blood plasma data
Updated on

The U.S. Food and Drug Administration has ousted its chief spokeswoman, said a person with knowledge of the move, days after the head of the agency exaggerated the benefits of an experimental coronavirus therapy and others in the Trump administration promoted the erroneous statements.

The spokeswoman, Emily Miller, joined the agency this month. She came to the job with communications experience in past government positions, a stint at conservative media outlets, and work advocating for gun rights, but little to no health-care experience.